Search results
Results From The WOW.Com Content Network
GenFleet Therapeutics has granted GFH009 rights to SELLAS Life Sciences Group Inc (NASDAQ: SLS) across all therapeutic and diagnostic uses worldwide outside of Greater China (mainland China, Hong ...
Number of employees. 60 (March 2014) Website. www.sellaslifesciences.com. Galena Biopharma, Inc. (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester, Massachusetts. In 2011, it moved to Oregon, [1][2] and in 2015 moved to San Ramon, California. [3]
SELLAS Life Sciences Group Inc (NASDAQ: SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian ...
It certainly was a quite a shock to see the SELLAS Life Sciences Group, Inc. ( NASDAQ:SLS ) share price fall -31% in... Shareholders Are Raving About How The SELLAS Life Sciences Group (NASDAQ:SLS ...
Life Sciences: Operates laboratories specialising in environmental monitoring, food and pharmaceutical, electronics, and consumer products market sectors. Commodities: Provides testing services for the global mining industry in service areas such as geochemistry , metallurgy , coal , mine site services and inspection.
It changed its name to “Prometic Life Sciences Inc.” on May 19, 1998 and subsequently rebranded to “Liminal BioSciences Inc.” on October 3, 2019. On July 28, 1998, the Company's common shares began trading on the Toronto Stock Exchange, or the TSX, under the trading symbol “PLI” and, on October 7, 2019, began trading under the ...
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In ...
Danaher had to sell off part of its life sciences businesses to Sartorius to satisfy the Federal Trade Commission regulatory requirement for the acquisition. [42] Cytiva is a global provider of technologies and services related to the development, manufacture, and delivery of vaccines, diagnostics, and therapeutics to customers in organizations ...